• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishGo to App
    Quantisnow Logo

    © 2026 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEWLLM Arena
    Legal
    Terms of usePrivacy policyCookie policy

    Stocks That Hit 52-Week Lows On Friday

    3/31/23 11:46:10 AM ET
    $SNTG
    $SPFI
    $SPRC
    $SYRS
    Finance: Consumer Services
    Finance
    Major Banks
    Finance
    Get the next $SNTG alert in real time by email

     

    On Friday, 93 stocks made new 52-week lows.

    Noteworthy Points From Today's 52-Week Lows:

    • Canopy Gwth (NASDAQ:CGC) was the largest, in terms of market cap, to set a new 52-week low.
    • Biodexa Pharmaceuticals (NASDAQ:BDRX) was the smallest company in terms of market cap to set a new 52-week low.
    • Ensysce Biosciences (NASDAQ:ENSC)'s stock moved significantly downwards, trading down 802.99% to reach a new 52-week low.
    • CXApp (NASDAQ:CXAI)'s stock bounced back the most, actually rising 0.01% after reaching its new 52-week low.

    On Friday, the following stocks broke to new 52-week lows:

    • Canopy Gwth (NASDAQ:CGC) stock hit a new 52-week low of $1.75. The stock was up 0.32% on the session.
    • Amerant Bancorp (NASDAQ:AMTB) stock hit a yearly low of $21.16. The stock was up 0.14% for the day.
    • Nikola (NASDAQ:NKLA) stock dropped to a yearly low on Friday of $1.15. Shares traded down 13.21%.
    • Great Southern Bancorp (NASDAQ:GSBC) shares set a new yearly low of $49.07 this morning. The stock was up 0.02% on the session.
    • Advantage Solutions (NASDAQ:ADV) stock set a new 52-week low of $1.56 on Friday, moving down 2.78%.
    • Heritage Commerce (NASDAQ:HTBK) shares set a new yearly low of $8.02 this morning. The stock was up 0.86% on the session.
    • Sharecare (NASDAQ:SHCR) shares hit a yearly low of $1.36. The stock was down 6.51% on the session.
    • First Community (NASDAQ:FCBC) stock achieved a new 52-week low on Friday morning, hitting $25.03 and moving up 0.36%.
    • Clover Health Investments (NASDAQ:CLOV) stock dropped to a yearly low on Friday of $0.82. Shares traded up 2.85%.
    • Tremor Intl (NASDAQ:TRMR) shares made a new 52-week low of $5.07 on Friday. The stock was up 0.39% for the day.
    • South Plains Financial (NASDAQ:SPFI) stock broke to a new 52-week low of $21.03 on Friday. Shares of the company traded up 1.13%.
    • Bank of Marin (NASDAQ:BMRC) stock hit a yearly low of $21.90. The stock was down 0.36% for the day.
    • Alerus Finl (NASDAQ:ALRS) stock hit a new 52-week low of $15.31. The stock was up 0.9% on the session.
    • Cano Health (NYSE:CANO) stock achieved a new 52-week low on Friday morning, hitting $0.76 and moving down 22.07%.
    • Kezar Life Sciences (NASDAQ:KZR) stock hit $3.12 on Friday morning, setting a new 52-week low for a change of up 2.37%.
    • Bankwell Finl Gr (NASDAQ:BWFG) stock hit a yearly low of $24.26. The stock was up 1.21% for the day.
    • Ocugen (NASDAQ:OCGN) stock achieved a new 52-week low on Friday morning, hitting $0.82 and moving up 3.72%.
    • Heron Therapeutics (NASDAQ:HRTX) stock hit a yearly low of $1.48. The stock was down 2.92% for the day.
    • YS Biopharma Co (NASDAQ:YS) shares moved down 9.31% on Friday to hit a new 52-week low of $1.82, drifting down 9.31%.
    • BP Prudhoe Bay (NYSE:BPT) shares were down 5.25% for the day, having made a 52-week low of $7.42.
    • Meta Materials (NASDAQ:MMAT) shares hit a yearly low of $0.41. The stock was up 1.56% on the session.
    • First Internet (NASDAQ:INBK) shares were up 0.66% for the day, having made a 52-week low of $16.35.
    • Investar Holding (NASDAQ:ISTR) shares fell to $13.89 on Friday, setting a new 52-week low with a shift of down 1.83%.
    • FLJ Group (NASDAQ:FLJ) stock drifted down 7.21% on Friday morning to hit a new 52-week low of $0.71.
    • Hanover Bancorp (NASDAQ:HNVR) shares reached a new 52-week low of $18.00 on Friday morning, moving up 0.82%.
    • Dragonfly Energy Hldgs (NASDAQ:DFLI) stock hit $2.54 on Friday morning, setting a new 52-week low for a change of down 4.46%.
    • Babylon Holdings (NYSE:BBLN) stock hit a yearly low of $4.61. The stock was up 0.41% for the day.
    • Arrival (NASDAQ:ARVL) stock set a new 52-week low of $0.13 on Friday, moving up 0.66%.
    • Veru (NASDAQ:VERU) shares were up 1.0% for the day, having made a 52-week low of $1.15.
    • Vinco Ventures (NASDAQ:BBIG) shares hit a yearly low of $0.31. The stock was up 0.28% on the session.
    • Finance of America (NYSE:FOA) stock hit $1.19 on Friday morning, setting a new 52-week low for a change of down 0.82%.
    • Virgin Orbit Holdings (NASDAQ:VORB) stock broke to a new 52-week low of $0.19 on Friday. Shares of the company traded down 40.75%.
    • Bioventus (NASDAQ:BVS) shares reached a new 52-week low of $0.80 on Friday morning, moving down 28.49%.
    • Enlivex Therapeutics (NASDAQ:ENLV) stock hit $3.36 on Friday morning, setting a new 52-week low for a change of up 1.72%.
    • JOANN (NASDAQ:JOAN) shares fell to $1.56 on Friday, setting a new 52-week low with a shift of down 7.1%.
    • Cyxtera Technologies (NASDAQ:CYXT) stock achieved a new 52-week low on Friday morning, hitting $0.34 and moving down 19.29%.
    • Jin Medical International (NASDAQ:ZJYL) shares set a new yearly low of $7.38 this morning. The stock was down 3.53% on the session.
    • Bed Bath & Beyond (NASDAQ:BBBY) stock hit a yearly low of $0.50. The stock was down 14.91% for the day.
    • Syros Pharmaceuticals (NASDAQ:SYRS) shares hit a yearly low of $2.61. The stock was down 3.31% on the session.
    • Advent Technologies Hldgs (NASDAQ:ADN) stock hit a yearly low of $0.94. The stock was down 15.38% for the day.
    • Praxis Precision Medicine (NASDAQ:PRAX) stock drifted up 1.42% on Friday morning to hit a new 52-week low of $0.79.
    • Chicken Soup for the Soul (NASDAQ:CSSE) stock hit a yearly low of $1.72. The stock was down 41.56% for the day.
    • HOOKIPA Pharma (NASDAQ:HOOK) stock broke to a new 52-week low of $0.70 on Friday. Shares of the company traded up 0.65%.
    • Fathom Digital Mfg (NYSE:FATH) shares hit a yearly low of $0.56. The stock was down 14.14% on the session.
    • Vicinity Motor (NASDAQ:VEV) shares moved down 10.04% on Friday to hit a new 52-week low of $0.70, drifting down 10.04%.
    • Chanson International (NASDAQ:CHSN) shares were up 0.81% for the day, having made a 52-week low of $1.86.
    • Checkpoint Therapeutics (NASDAQ:CKPT) shares made a new 52-week low of $1.85 on Friday. The stock was down 34.87% for the day.
    • SAB Biotherapeutics (NASDAQ:SABS) stock achieved a new 52-week low on Friday morning, hitting $0.40 and moving up 2.7%.
    • ICZOOM Group (NASDAQ:IZM) shares fell to $2.04 on Friday, setting a new 52-week low with a shift of down 5.48%.
    • CXApp (NASDAQ:CXAI) stock set a new 52-week low of $1.43 on Friday, moving up 0.01%.
    • SMX (Security Matters) (NASDAQ:SMX) stock dropped to a yearly low on Friday of $0.91. Shares traded down 2.11%.
    • Mangoceuticals (NASDAQ:MGRX) stock drifted down 7.59% on Friday morning to hit a new 52-week low of $1.28.
    • ENGlobal (NASDAQ:ENG) shares moved down 3.0% on Friday to hit a new 52-week low of $0.46, drifting down 3.0%.
    • Aeglea BioTherapeutics (NASDAQ:AGLE) shares moved down 0.21% on Friday to hit a new 52-week low of $0.28, drifting down 0.21%.
    • Lucy Scientific Discovery (NASDAQ:LSDI) stock drifted down 5.31% on Friday morning to hit a new 52-week low of $1.03.
    • Atlis Motor Vehicles (NASDAQ:AMV) shares set a new 52-week low of $0.55. The stock traded down 2.9%.
    • Asset Entities (NASDAQ:ASST) stock dropped to a yearly low on Friday of $1.37. Shares traded down 3.45%.
    • Shapeways Hldgs (NYSE:SHPW) stock hit a yearly low of $0.31. The stock was down 20.5% for the day.
    • Future FinTech Gr (NASDAQ:FTFT) stock hit a yearly low of $1.04. The stock was up 1.89% for the day.
    • Infinity Pharmaceuticals (NASDAQ:INFI) shares moved down 5.78% on Friday to hit a new 52-week low of $0.16, drifting down 5.78%.
    • AEterna Zentaris (NASDAQ:AEZS) stock set a new 52-week low of $2.49 on Friday, moving down 7.09%.
    • Aridis Pharmaceuticals (NASDAQ:ARDS) shares made a new 52-week low of $0.31 on Friday. The stock was down 6.5% for the day.
    • Akari Therapeutics (NASDAQ:AKTX) shares were up 3.47% for the day, having made a 52-week low of $0.14.
    • Nogin (NASDAQ:NOGN) shares set a new yearly low of $2.57 this morning. The stock was down 22.87% on the session.
    • Jaguar Health (NASDAQ:JAGX) shares fell to $0.65 on Friday, setting a new 52-week low with a shift of down 4.52%.
    • Bit Brother (NASDAQ:BTB) shares hit a yearly low of $0.83. The stock was down 22.03% on the session.
    • OceanPal (NASDAQ:OP) shares were down 3.02% for the day, having made a 52-week low of $0.34.
    • Aptinyx (NASDAQ:APTX) stock hit a yearly low of $0.12. The stock was down 6.37% for the day.
    • Biolase (NASDAQ:BIOL) shares fell to $0.27 on Friday, setting a new 52-week low with a shift of down 4.73%.
    • mCloud Technologies (NASDAQ:MCLD) shares were down 13.81% for the day, having made a 52-week low of $0.30.
    • ENDRA Life Sciences (NASDAQ:NDRA) shares reached a new 52-week low of $2.20 on Friday morning, moving down 12.31%.
    • Charah Solns (NYSE:CHRA) stock hit $2.03 on Friday morning, setting a new 52-week low for a change of down 19.77%.
    • Marker Therapeutics (NASDAQ:MRKR) shares set a new 52-week low of $0.74. The stock traded down 4.92%.
    • Netcapital (NASDAQ:NCPL) shares reached a new 52-week low of $0.95 on Friday morning, moving down 0.39%.
    • Aileron Therapeutics (NASDAQ:ALRN) shares moved down 0.76% on Friday to hit a new 52-week low of $1.24, drifting down 0.76%.
    • Gaucho Group Holdings (NASDAQ:VINO) stock dropped to a yearly low on Friday of $0.91. Shares traded down 3.12%.
    • Tivic Health Systems (NASDAQ:TIVC) stock drifted down 11.05% on Friday morning to hit a new 52-week low of $0.15.
    • Sentage Hldgs (NASDAQ:SNTG) shares were down 7.56% for the day, having made a 52-week low of $1.55.
    • BiondVax Pharmaceuticals (NASDAQ:BVXV) shares were down 3.74% for the day, having made a 52-week low of $2.03.
    • Harbor Custom Dev (NASDAQ:HCDI) stock hit a new 52-week low of $4.77. The stock was down 5.31% on the session.
    • SciSparc (NASDAQ:SPRC) shares hit a yearly low of $0.46. The stock was down 2.1% on the session.
    • Clearmind Medicine (NASDAQ:CMND) stock hit $1.17 on Friday morning, setting a new 52-week low for a change of down 5.42%.
    • Kiromic BioPharma (NASDAQ:KRBP) shares made a new 52-week low of $3.16 on Friday. The stock was up 3.63% for the day.
    • Mobiquity Technologies (NASDAQ:MOBQ) stock set a new 52-week low of $0.17 on Friday, moving down 4.28%.
    • ContraFect (NASDAQ:CFRX) stock dropped to a yearly low on Friday of $1.73. Shares traded down 17.3%.
    • Fresh Tracks Therapeutics (NASDAQ:FRTX) stock hit $0.66 on Friday morning, setting a new 52-week low for a change of down 3.64%.
    • G Medical Innovations (NASDAQ:GMVD) stock set a new 52-week low of $0.90 on Friday, moving down 42.96%.
    • Allarity Therapeutics (NASDAQ:ALLR) shares hit a yearly low of $1.65. The stock was down 5.68% on the session.
    • Biodexa Pharmaceuticals (NASDAQ:BDRX) shares reached a new 52-week low of $0.30 on Friday morning, moving down 25.47%.

    Be sure to stay with Benzinga for further updates and market-moving news. And if you want to be among the first to know about the 52-week highs and lows for the day, check out Benzinga Pro. Users receive a daily alert listing stocks trading near 52-week highs and lows each morning. Click here to learn more.

    Get the next $SNTG alert in real time by email

    Crush Q1 2026 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $SNTG
    $SPFI
    $SPRC
    $SYRS

    CompanyDatePrice TargetRatingAnalyst
    Investar Holding Corporation
    $ISTR
    4/23/2026$31.50Overweight → Neutral
    Piper Sandler
    Strive Inc.
    $ASST
    4/21/2026$36.00Buy
    H.C. Wainwright
    Strive Inc.
    $ASST
    4/10/2026$26.00Buy
    TD Cowen
    Praxis Precision Medicines Inc.
    $PRAX
    4/10/2026$815.00Strong Buy
    Raymond James
    Akari Therapeutics plc
    $AKTX
    4/8/2026Buy → Hold
    Maxim Group
    SAB Biotherapeutics Inc.
    $SABS
    4/3/2026$13.00Buy
    Rodman & Renshaw
    Finance of America Companies Inc.
    $FOA
    4/3/2026$22.50Buy
    B. Riley Securities
    SAB Biotherapeutics Inc.
    $SABS
    4/2/2026$13.00Buy
    Rodman & Renshaw
    More analyst ratings

    $SNTG
    $SPFI
    $SPRC
    $SYRS
    Insider Purchases

    Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Chief Financial Officer Engel Matthew A bought $174,402 worth of shares (10,600 units at $16.45), increasing direct ownership by 46% to 33,436 units (SEC Form 4)

    4 - Finance of America Companies Inc. (0001828937) (Issuer)

    3/17/26 4:42:00 PM ET
    $FOA
    Finance: Consumer Services
    Finance

    Director Jordan Robert Chris bought $41,618 worth of shares (1,550 units at $26.85), increasing direct ownership by 3% to 58,798 units (SEC Form 4)

    4 - Investar Holding Corp (0001602658) (Issuer)

    3/16/26 4:38:58 PM ET
    $ISTR
    Major Banks
    Finance

    Large owner Cooperman Leon G bought $451 worth of shares (28 units at $16.10) (SEC Form 4)

    4 - Finance of America Companies Inc. (0001828937) (Issuer)

    3/16/26 4:06:53 PM ET
    $FOA
    Finance: Consumer Services
    Finance

    $SNTG
    $SPFI
    $SPRC
    $SYRS
    SEC Filings

    View All

    Tivic Health Systems Inc. filed SEC Form 8-K: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year, Financial Statements and Exhibits

    8-K - Tivic Health Systems, Inc. (0001787740) (Filer)

    4/23/26 4:36:54 PM ET
    $TIVC
    Biotechnology: Electromedical & Electrotherapeutic Apparatus
    Health Care

    Amerant Bancorp Inc. filed SEC Form 8-K: Results of Operations and Financial Condition, Regulation FD Disclosure, Other Events, Financial Statements and Exhibits

    8-K - Amerant Bancorp Inc. (0001734342) (Filer)

    4/23/26 4:31:34 PM ET
    $AMTB
    Major Banks
    Finance

    SEC Form DEF 14A filed by Hanover Bancorp Inc.

    DEF 14A - Hanover Bancorp, Inc. /MD (0001828588) (Filer)

    4/23/26 4:00:29 PM ET
    $HNVR
    Major Banks
    Finance

    $SNTG
    $SPFI
    $SPRC
    $SYRS
    FDA approvals

    Live FDA approvals issued by the Food and Drug Administration and FDA breaking news

    View All

    FDA Approval for ZYNRELEF KIT issued to HERON THERAPS INC

    Submission status for HERON THERAPS INC's drug ZYNRELEF KIT (SUPPL-18) with active ingredient BUPIVACAINE; MELOXICAM has changed to 'Approval' on 11/21/2024. Application Category: NDA, Application Number: 211988, Application Classification: Labeling

    11/22/24 4:36:11 AM ET
    $HRTX
    Biotechnology: Pharmaceutical Preparations
    Health Care

    FDA Approval for APONVIE issued to HERON THERAPS INC

    Submission status for HERON THERAPS INC's drug APONVIE (SUPPL-3) with active ingredient APREPITANT has changed to 'Approval' on 03/05/2024. Application Category: NDA, Application Number: 216457, Application Classification: Labeling

    3/11/24 4:38:31 AM ET
    $HRTX
    Biotechnology: Pharmaceutical Preparations
    Health Care

    FDA Approval for CINVANTI issued to HERON THERAPS INC

    Submission status for HERON THERAPS INC's drug CINVANTI (SUPPL-15) with active ingredient APREPITANT has changed to 'Approval' on 03/05/2024. Application Category: NDA, Application Number: 209296, Application Classification: Labeling

    3/11/24 4:38:29 AM ET
    $HRTX
    Biotechnology: Pharmaceutical Preparations
    Health Care

    $SNTG
    $SPFI
    $SPRC
    $SYRS
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    SEC Form 4 filed by Growe Christopher

    4 - Advantage Solutions Inc. (0001776661) (Issuer)

    4/22/26 4:30:05 PM ET
    $ADV
    Real Estate

    SEC Form 4 filed by Prahm Jeremy

    4 - Finance of America Companies Inc. (0001828937) (Issuer)

    4/22/26 4:31:09 PM ET
    $FOA
    Finance: Consumer Services
    Finance

    SEC Form 4 filed by Taylor Michael Larry

    4 - Advantage Solutions Inc. (0001776661) (Issuer)

    4/22/26 4:30:03 PM ET
    $ADV
    Real Estate

    $SNTG
    $SPFI
    $SPRC
    $SYRS
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    View All

    Investar downgraded by Piper Sandler with a new price target

    Piper Sandler downgraded Investar from Overweight to Neutral and set a new price target of $31.50

    4/23/26 7:48:05 AM ET
    $ISTR
    Major Banks
    Finance

    H.C. Wainwright initiated coverage on Strive with a new price target

    H.C. Wainwright initiated coverage of Strive with a rating of Buy and set a new price target of $36.00

    4/21/26 7:35:41 AM ET
    $ASST
    Computer Software: Prepackaged Software
    Technology

    TD Cowen initiated coverage on Strive with a new price target

    TD Cowen initiated coverage of Strive with a rating of Buy and set a new price target of $26.00

    4/10/26 8:35:32 AM ET
    $ASST
    Computer Software: Prepackaged Software
    Technology

    $SNTG
    $SPFI
    $SPRC
    $SYRS
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    Amerant Reports First Quarter 2026 Results

    Amerant Bancorp Inc. (NYSE:AMTB) (the "Company" or "Amerant") today reported net income attributable to the Company of $17.9 million in the first quarter of 2026, or $0.44 earnings per diluted share, compared to net income of $2.7 million, or $0.07 earnings per diluted share, in the fourth quarter of 2025. "Amerant's first quarter results reflect continued momentum in executing our strategic plan as we strengthen credit quality and position the bank for sustainable, long-term growth," stated Carlos Iafigliola, SEVP and Interim CEO. "During the quarter, we demonstrated proactive credit risk management, which led to balanced portfolio actions. We also continued to optimize our loan portfoli

    4/23/26 4:30:00 PM ET
    $AMTB
    Major Banks
    Finance

    Amerant Bancorp Inc. Declares Dividend

    Amerant Bancorp Inc. (NYSE:AMTB) (the "Company" or "Amerant") today announced that, on April 22, 2026, the Company's Board of Directors declared a cash dividend of $0.09 per-share of Amerant common stock. The dividend is payable on May 29, 2026, to shareholders of record at the close of business on May 15, 2026. About Amerant Bancorp Inc. (NYSE:AMTB) Amerant Bancorp Inc. is a bank holding company headquartered in Coral Gables, Florida since 1979. The Company operates through its main subsidiary, Amerant Bank, N.A. (the "Bank"), as well as its other subsidiary, Amerant Investments, Inc. The Company provides individuals and businesses with deposit, credit and wealth management services. T

    4/23/26 4:30:00 PM ET
    $AMTB
    Major Banks
    Finance

    Tivic Health Systems Rebrands as Valion Bio, Reflecting Completed Transformation into a Late-Stage Biopharmaceutical Company with Government-Backed Asset and Potential Multiple Revenue Stream Model

    Ticker Symbol to Change from TIVC to VBIO Effective April 28, 2026; Company Advancing Entolimod™ Toward BARDA Funding and Strategic National Stockpile Procurement While Velocity Bioworks CDMO Builds Independent Revenue BaseSAN ANTONIO, April 23, 2026 /PRNewswire/ -- Tivic Health Systems, Inc. (NASDAQ:TIVC) today announced it is changing its corporate name to Valion Bio, Inc. and its Nasdaq ticker symbol from TIVC to VBIO, effective at market open on Tuesday, April 28, 2026. The CUSIP number for the company's common stock will remain unchanged. The rebrand is not merely cosmetic.

    4/23/26 4:05:00 PM ET
    $TIVC
    Biotechnology: Electromedical & Electrotherapeutic Apparatus
    Health Care

    $SNTG
    $SPFI
    $SPRC
    $SYRS
    Leadership Updates

    Live Leadership Updates

    View All

    'There's a Tweed for That': Canopy Growth Announces Tweed Brand Summer Campaign

    New window bags, improved potency, and sharper pricing arrive at retail Victoria Day long weekend Canopy Growth Corporation ("Canopy Growth", "Canopy" or the "Company") (TSX:WEED) (NASDAQ:CGC) today announced a refresh of Tweed, one of Canada's most recognizable cannabis brands, alongside a national summer campaign, "There's a Tweed for That." This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260423388138/en/The Tweed summer campaign launches over the Victoria Day long weekend, the traditional kickoff to the Canadian summer, spotlighting Tweed's updated portfolio, including three new flower strains and the popular Quickies pre-ro

    4/23/26 7:30:00 AM ET
    $CGC
    Medicinal Chemicals and Botanical Products
    Health Care

    Netcapital Appoints Todd Violette as Chief Executive Officer

    BOSTON, MA, April 16, 2026 (GLOBE NEWSWIRE) -- Netcapital Inc. (NASDAQ:NCPL, NCPLW)) (the "Company"), a publicly traded fintech company that gives companies access to capital markets infrastructure without institutional-scale fees, today announced that its Board of Directors has appointed Mr. Violette to lead the Company in order to accelerate capital formation, expand platform reach, and build long-term shareholder value. Mr. Violette brings over 25 years of leadership experience across capital markets, fintech and digital asset-related businesses. His recent operating and executive roles have included CEO of CloudCover International, CEO of AppYea Inc., CEO of Vinergy, Chief Investment

    4/16/26 4:05:00 PM ET
    $NCPL
    Finance: Consumer Services
    Finance

    Bed Bath & Beyond Names Veteran Retail Operator Amy Sullivan President

    Bed Bath & Beyond, Inc. (NYSE:BBBY) ("Bed Bath & Beyond" or the "Company"), owner of Bed Bath & Beyond, Overstock, buybuy BABY, Kirkland's, and a blockchain asset portfolio, today announced the appointment of Amy Sullivan as President, effective immediately, as the Company accelerates its next phase of disciplined growth. Sullivan is a merchant and operator who built her career across some of retail's most recognized brands, including JCPenney, Kohl's, Lands' End, Express, and Lane Bryant, before joining Kirkland's in 2012, where she rose from divisional merchandise manager to President and CEO. As CEO of The Brand House Collective, the operating entity she led through its transformation

    4/6/26 8:30:00 AM ET
    $BBBY
    Catalog/Specialty Distribution
    Consumer Discretionary

    $SNTG
    $SPFI
    $SPRC
    $SYRS
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    View All

    Amendment: SEC Form SC 13D/A filed by Finance of America Companies Inc.

    SC 13D/A - Finance of America Companies Inc. (0001828937) (Subject)

    12/11/24 8:30:03 PM ET
    $FOA
    Finance: Consumer Services
    Finance

    Amendment: SEC Form SC 13D/A filed by Akari Therapeutics plc

    SC 13D/A - Akari Therapeutics Plc (0001541157) (Subject)

    12/6/24 4:00:28 PM ET
    $AKTX
    Biotechnology: Pharmaceutical Preparations
    Health Care

    Amendment: SEC Form SC 13D/A filed by OceanPal Inc.

    SC 13D/A - OceanPal Inc. (0001869467) (Subject)

    12/2/24 4:18:52 PM ET
    $OP
    Marine Transportation
    Consumer Discretionary

    $SNTG
    $SPFI
    $SPRC
    $SYRS
    Financials

    Live finance-specific insights

    View All

    Amerant Reports First Quarter 2026 Results

    Amerant Bancorp Inc. (NYSE:AMTB) (the "Company" or "Amerant") today reported net income attributable to the Company of $17.9 million in the first quarter of 2026, or $0.44 earnings per diluted share, compared to net income of $2.7 million, or $0.07 earnings per diluted share, in the fourth quarter of 2025. "Amerant's first quarter results reflect continued momentum in executing our strategic plan as we strengthen credit quality and position the bank for sustainable, long-term growth," stated Carlos Iafigliola, SEVP and Interim CEO. "During the quarter, we demonstrated proactive credit risk management, which led to balanced portfolio actions. We also continued to optimize our loan portfoli

    4/23/26 4:30:00 PM ET
    $AMTB
    Major Banks
    Finance

    Amerant Bancorp Inc. Declares Dividend

    Amerant Bancorp Inc. (NYSE:AMTB) (the "Company" or "Amerant") today announced that, on April 22, 2026, the Company's Board of Directors declared a cash dividend of $0.09 per-share of Amerant common stock. The dividend is payable on May 29, 2026, to shareholders of record at the close of business on May 15, 2026. About Amerant Bancorp Inc. (NYSE:AMTB) Amerant Bancorp Inc. is a bank holding company headquartered in Coral Gables, Florida since 1979. The Company operates through its main subsidiary, Amerant Bank, N.A. (the "Bank"), as well as its other subsidiary, Amerant Investments, Inc. The Company provides individuals and businesses with deposit, credit and wealth management services. T

    4/23/26 4:30:00 PM ET
    $AMTB
    Major Banks
    Finance

    Finance of America Announces First Quarter 2026 Earnings Release and Conference Call on May 5, 2026

    Finance of America Companies Inc. ("Finance of America" or the "Company") (NYSE:FOA), a leading provider of home equity-based financing solutions for a modern retirement, today announced that it will release results for the first quarter ended March 31, 2026 after market closing on Tuesday, May 5, 2026. Webcast and Earnings Conference Call Management will host a webcast and conference call on the same day at 5:00 pm Eastern Time to discuss the Company's results for the first quarter ended March 31, 2026. A copy of the press release and investor presentation will be posted prior to the call under the "Investors" section on Finance of America's investor-oriented website at https://ir.fina

    4/22/26 4:05:00 PM ET
    $FOA
    Finance: Consumer Services
    Finance

    $SNTG
    $SPFI
    $SPRC
    $SYRS
    Insider purchases explained

    Analytical look into recent insider purchases

    View All

    Financial Insight: Purchase at Clover Health Investments Corp. on Jun 20

    The recent insider purchase at Clover Health Investments Corp. by Director Garipalli Vivek on June 20, 2024, has caught the attention of investors. Director Garipalli Vivek bought $1,000,426 worth of shares, acquiring 877,567 units at $1.14 per share, as reported in SEC Form 4. This insider purchase stands out among recent insider transactions at Clover Health. Looking at the previous transactions, there have been instances of insiders covering exercise/tax liability by selling shares, resulting in a decrease in their direct ownership percentages. For example, Reynoso Jamie L., Priest Brady Patrick, Toy Andrew, Sharp Aric R, Soares Karen, Chief Technology Officer Wai Conrad, and CEO Reynoso

    6/20/24 6:36:05 PM ET
    $CLOV
    Medical Specialities
    Health Care